- Home
- ISPR vs SGMO Comparison
ISPR vs SGMO Comparison
Compare ISPR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- SGMO
- Stock Information
- Founded
- ISPR 2010
- SGMO 1995
- Country
- ISPR United States
- SGMO United States
- Employees
- ISPR N/A
- SGMO N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPR Health Care
- SGMO Health Care
- Exchange
- ISPR Nasdaq
- SGMO Nasdaq
- Market Cap
- ISPR 152.0M
- SGMO 122.8M
- IPO Year
- ISPR 2023
- SGMO 2000
- Fundamental
- Price
- ISPR $2.44
- SGMO $0.73
- Analyst Decision
- ISPR Strong Buy
- SGMO Strong Buy
- Analyst Count
- ISPR 1
- SGMO 7
- Target Price
- ISPR $7.50
- SGMO $5.29
- AVG Volume (30 Days)
- ISPR 52.5K
- SGMO 5.7M
- Earning Date
- ISPR 11-10-2025
- SGMO 11-11-2025
- Dividend Yield
- ISPR N/A
- SGMO N/A
- EPS Growth
- ISPR N/A
- SGMO N/A
- EPS
- ISPR N/A
- SGMO N/A
- Revenue
- ISPR $127,494,304.00
- SGMO $81,706,000.00
- Revenue This Year
- ISPR $60.96
- SGMO $28.47
- Revenue Next Year
- ISPR $23.96
- SGMO N/A
- P/E Ratio
- ISPR N/A
- SGMO N/A
- Revenue Growth
- ISPR N/A
- SGMO 565.52
- 52 Week Low
- ISPR $2.09
- SGMO $0.41
- 52 Week High
- ISPR $7.47
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ISPR 40.32
- SGMO 71.94
- Support Level
- ISPR $2.27
- SGMO $0.65
- Resistance Level
- ISPR $2.65
- SGMO $0.73
- Average True Range (ATR)
- ISPR 0.20
- SGMO 0.06
- MACD
- ISPR -0.04
- SGMO 0.01
- Stochastic Oscillator
- ISPR 27.46
- SGMO 88.83
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.